Compare Bank of Montreal (BMO) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs GSK plc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while GSK plc trades at $50.56 (market cap $102.60B). The key difference: Bank of Montreal is the larger of the two by market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| BMO | GSK | |
|---|---|---|
Market Cap | $126.83B | $102.60B |
Sector | Financials | Health |
52-Week High | $183.65 | $61.18 |
52-Week Low | $112.54 | $38.22 |
Dividend Yield | 2.69% | 3.57% |
Enterprise Value | — | $123.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
